We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.77B
AUM Growth
-$242M
Cap. Flow
-$349M
Cap. Flow %
-12.6%
Top 10 Hldgs %
18.23%
Holding
319
New
33
Increased
50
Reduced
134
Closed
77

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$30.5M
2
AHCO icon
AdaptHealth
AHCO
+$26.6M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$19.6M
4
BJRI icon
BJ's Restaurants
BJRI
+$17.7M
5
SI
Silvergate Capital Corporation
SI
+$16.5M

Top Sells

Rank Stock Value
1
MNTV
Momentive Global Inc. Common Stock
MNTV
+$35.4M
2
NFE icon
New Fortress Energy
NFE
+$28.3M
3
IMVT icon
Immunovant
IMVT
+$27.9M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$25M
5
TMHC icon
Taylor Morrison
TMHC
+$23.8M

Sector Composition

Rank Sector Weight
1 Healthcare 22.04%
2 Technology 19.82%
3 Consumer Discretionary 16.91%
4 Industrials 13.94%
5 Financials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REPL icon
26
Replimune Group
REPL
$859M
$28.6M 1.03%
938,001
+55,537
+6% +$2.08M
AZEK
27
DELISTED
The AZEK Co
AZEK
$28M 1.01%
665,324
+4,420
+0.7% +$189K
AHCO icon
28
AdaptHealth
AHCO
$1.49B
$27.8M 1%
756,733
+753,155
+21,050% +$26.6M
EYE icon
29
National Vision
EYE
$1.66B
$27.4M 0.99%
624,762
-76,225
-11% -$3.63M
PRKS icon
30
United Parks & Resorts
PRKS
$2.13B
$26.9M 0.97%
541,922
+54,860
+11% +$2.17M
RETA
31
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$26.1M 0.94%
+261,467
New +$30.5M
LOB icon
32
Live Oak Bancshares
LOB
$1.97B
$26M 0.94%
379,857
+162,605
+75% +$8.53M
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.88B
$26M 0.94%
228,368
+1,493
+0.7% +$203K
ONT
34
Onterris Inc
ONT
$756M
$26M 0.94%
518,057
-63,746
-11% -$2.69M
VIAV icon
35
Viavi Solutions
VIAV
$9.41B
$25.9M 0.93%
1,647,899
-12,397
-0.7% -$200K
COHU icon
36
Cohu
COHU
$2.41B
$25.6M 0.92%
610,963
+279,736
+84% +$12.3M
MODN
37
DELISTED
MODEL N, INC.
MODN
$25.5M 0.92%
722,693
-54,014
-7% -$2.08M
DKS icon
38
Dick's Sporting Goods
DKS
$19.5B
$25.3M 0.91%
332,446
-64,877
-16% -$4.67M
BPMC
39
DELISTED
Blueprint Medicines
BPMC
$25.3M 0.91%
260,134
-37,771
-13% -$3.77M
IBP icon
40
Installed Building Products
IBP
$6.16B
$25.3M 0.91%
227,782
-24,674
-10% -$2.8M
PRFT
41
DELISTED
Perficient Inc
PRFT
$25.2M 0.91%
429,167
-21,030
-5% -$1.19M
TMDX icon
42
Transmedics
TMDX
$2.56B
$25.1M 0.91%
604,975
-67,905
-10% -$2.09M
YETI icon
43
Yeti Holdings
YETI
$3.87B
$25M 0.9%
345,784
-43,330
-11% -$3.09M
EVRI
44
DELISTED
Everi Holdings
EVRI
$24.8M 0.9%
1,759,995
+99,995
+6% +$1.42M
PLNT icon
45
Planet Fitness
PLNT
$4.14B
$24.6M 0.89%
318,215
-49,610
-13% -$3.94M
NVEE
46
DELISTED
NV5 Global
NVEE
$24.4M 0.88%
1,012,732
-146,480
-13% -$3.49M
LSCC icon
47
Lattice Semiconductor
LSCC
$17.2B
$23.2M 0.84%
514,905
-63,510
-11% -$2.82M
ARNA
48
DELISTED
Arena Pharmaceuticals Inc
ARNA
$22.7M 0.82%
327,107
-37,285
-10% -$2.87M
PLMR icon
49
Palomar
PLMR
$3.59B
$22.6M 0.81%
336,552
-41,530
-11% -$3.73M
MAX icon
50
MediaAlpha
MAX
$763M
$22.5M 0.81%
635,133
+88,712
+16% +$4.4M
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, Emerald Advisers held 319 positions worth $2.77B, down 8% from $3.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $349M in Q1 2021, closing 77 positions and reducing 134 holdings. Its most notable exit was Momentive Global Inc. Common Stock, an estimated $35.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $26.1M.

  • Emerald Advisers's largest Q1 2021 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 261,467 shares worth $26.1M.
  • Emerald Advisers added most to AdaptHealth in Q1 2021, an estimated $26.6M increase.
  • Emerald Advisers's biggest Q1 2021 reduction was New Fortress Energy, cutting an estimated $28.3M.
  • Emerald Advisers fully exited Momentive Global Inc. Common Stock in Q1 2021, selling an estimated $35.4M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.77B portfolio in Q1 2021.
  • Emerald Advisers opened 33 new positions and closed 77 in Q1 2021.
  • Emerald Advisers's portfolio value fell 8% quarter-over-quarter to $2.77B.

Based on Emerald Advisers's 13F filing for Q1 2021, filed 29 Apr 2021.